Actively Recruiting
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
Led by Jiangsu HengRui Medicine Co., Ltd. · Updated on 2026-04-17
55
Participants Needed
1
Research Sites
85 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of SHR-3167 at steady state in subjects with type 2 diabetes.
CONDITIONS
Official Title
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provided informed consent before any study activities
- Age between 18 and 59 years at screening
- Diagnosed with type 2 diabetes mellitus for at least 6 months before screening
- Female participants of childbearing potential and their male partners agree to use highly effective contraception for 3 months after consent and have no plans to donate eggs or sperm
- Female participants of childbearing potential have a negative pregnancy test during screening and are not breastfeeding
You will not qualify if you...
- Poor blood pressure control at screening
- Known or suspected allergy to the study drug or similar products, or history of multiple or severe allergies to drugs or foods
- Serious cardiovascular or cerebrovascular diseases within 6 months prior to screening
- Positive tests for hepatitis B surface antigen, HIV antibody, syphilis antibody, or hepatitis C virus antibody, or active/incubation phase of these infections
- History of cancer or malignancy within 5 years prior to screening
- Participation in any clinical trial of approved or unapproved investigational drugs or medical devices within 90 days prior to screening
- Any other condition the investigator believes may affect safety or interfere with study results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
West China Hospital of Sichuan University
Chengdu, Sichuan, China, 200433
Actively Recruiting
Research Team
H
Han Jianting
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here